| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 208.418 | 84 |
| GSM780708 | Untreated after 4 days (C2_1) | 201.371 | 84 |
| GSM780709 | Untreated after 4 days (C3_1) | 213.44 | 84 |
| GSM780719 | Untreated after 4 days (C1_2) | 236.382 | 85 |
| GSM780720 | Untreated after 4 days (C2_2) | 163.358 | 81 |
| GSM780721 | Untreated after 4 days (C3_2) | 164.374 | 81 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 232.081 | 85 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 198.663 | 83 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 229.21 | 85 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 230.833 | 85 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 173.747 | 82 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 185.273 | 83 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 210.391 | 84 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 217.938 | 84 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 231.22 | 85 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 165.249 | 82 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 208.477 | 84 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 209.59 | 84 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 164.717 | 81 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 215.248 | 84 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 217.212 | 84 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 159.672 | 81 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 169.768 | 82 |